MedPath

Dermacyd Infantile (Lactic Acid) - Photo Evaluation.

Phase 4
Completed
Conditions
Hygiene
Interventions
Drug: LACTIC ACID(ND)
Registration Number
NCT00881348
Lead Sponsor
Sanofi
Brief Summary

Primary Objective:

To demonstrate the absence of photo irritation and photosensitization potential of the product Dermacyd Infantile (Lactic Acid).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Dermacyd infantile (Lactic Acid)LACTIC ACID(ND)5 weeks treatment
Primary Outcome Measures
NameTimeMethod
The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. The sensibility will be evaluated according to the skin type.During 5 weeks (i.e. treatment period)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sanofi-Aventis Administrative Office

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath